RBCC Issues Shareholder Letter Celebrating Promising 2013

  RBCC Issues Shareholder Letter Celebrating Promising 2013

Business Wire

NOKOMIS, Fla. -- December 03, 2012

Rainbow Coral Corp. (OTCBB: RBCC) President and CEO Patrick Brown issued the
following open letter to shareholders this morning discussing the company’s
success in 2012 and big plans for the future:

Dear Shareholders:

Thank you for helping to make 2012 a huge success for Rainbow Coral Corp. The
coming year will be even better, and we’re looking forward to announcing some
exciting news that we’re certain will generate buzz and boost shareholder
value in 2013.

Before we reveal our big plans for the future, however, let’s take a look back
at all we’ve accomplished in 2012—our first full year in business.

One of the most exciting developments this year was the deepening relationship
between our company and Amarantus BioSciences. Amarantus is on the cutting
edge of biotech innovations, and when our joint venture is finalized, we plan
to move forward aggressively toward swift profitability.

Our first priority will be commercialization of Amarantus’ incredible new
breakthrough, NuroPro. The test has already completed a Phase 1 human clinical
trial. Initiating Phase 2 clinical studies will be tops on our agenda next
year. Upon completing Phase 2, NuroPro could begin generating revenue through
sales under the Clinical Laboratory Improvement Amendment (CLIA)
certification.

Next up will be MANF, the groundbreaking new therapeutic protein that
Amarantus is developing to treat Parkinson’s disease and traumatic brain
injuries. As the world’s population ages and neurological disorders become
more prevalent, this could become a major source of revenue for our company
soon. Stay tuned.

As many of us are aware, the cure to deadly diseases such as Parkinson’s,
Alzheimer’s, and others could be developed someday soon using new stem cell
treatments now being investigated. Thanks to adult stem cell technology, the
moral objections to stem cell research are beginning to disappear, indicating
a bright future for medical breakthroughs.

This year, our joint venture partner Nano3D BioSciences (n3D) demonstrated the
impressive potential of its magnetic-levitation cell culturing system known as
the Bio-Assembler. The Bio-Assembler’s fusion of magnetic levitation and
nanoparticle assembly technology allows it to produce accurate, 3D
representations ofin vivotissues faster and easier than any other existing
tools.

In 2013, the Bio-Assembler is slated to be put to use in high-profile cancer
research at the University of Texas Health Science Center at Houston in the
Texas Medical Center. As word spreads about the value this technology brings
to stem cell research, we expect to see an explosion in interest from
top-flight researchers around the world.

We look forward to your continued support as we plan a tremendous year for
RBCC and our shareholders in 2013. The best is yet to come for this company as
we strive to grow our business worldwide. Enjoy the holidays, and thank you
for being a part of Rainbow Coral Corp.!

About Rainbow BioSciences

Rainbow BioSciences, LLC, is a wholly owned subsidiary of Rainbow Coral Corp.
(OTCBB:RBCC). The company continually seeks out new partnerships with
biotechnology developers to deliver profitable new medical technologies and
innovations. For more information on our growth-oriented business initiatives,
please visit our website at [http://www.RainbowBioSciences.com]. For
investment information and performance data on the company, please visit
www.RainbowBioSciences.com/investors.html.

Notice Regarding Forward-Looking Statements

Safe Harbor Statement under the Private Securities Litigation Reform Act of
1995: This news release contains forward-looking information within the
meaning of Section 27A of the Securities Act of 1933, as amended, and Section
21E of the Securities Exchange Act of 1934, as amended, including statements
that include the words "believes," "expects," "anticipate" or similar
expressions. Such forward-looking statements involve known and unknown risks,
uncertainties and other factors that may cause the actual results, performance
or achievements of the company to differ materially from those expressed or
implied by such forward-looking statements. In addition, description of
anyone's past success, either financial or strategic, is no guarantee of
future success. This news release speaks as of the date first set forth above
and the company assumes no responsibility to update the information included
herein for events occurring after the date hereof.

Contact:

Rainbow Coral Corp.
Patrick Brown, 813-367-9511
President and CEO
info@rainbowcoral.com